LC– and CZE–ICP-MS approaches for the in vivo analysis of the anticancer drug candidate sodium trans-[tetrachloridobis(1H-indazole)ruthenate(iii)] (KP1339) in mouse plasma
2014 ◽
Vol 11
(7)
◽
pp. 825-832
◽
2021 ◽
Vol 6
(3)
◽
pp. 48-60
Keyword(s):
2012 ◽
Vol 9
(9)
◽
pp. 815-822
◽
2017 ◽
Vol 132
◽
pp. 232-236
◽
1997 ◽
Vol 103
(1)
◽
pp. 154